Astrazeneca Pharmaceuticals LP
Lobbying group · Jul 2025 – Sep 2026
Astrazeneca Pharmaceuticals LP spent $6M lobbying the federal government (Jul 2025 – Sep 2026), mostly on medicare & medicaid, health care, pharmacy. It used 8 lobbyists, including people who worked for 3 members of Congress.
- Spent on lobbying
- $6M
- Lobbyists
- 8
- Bills lobbied
- 12
- Issues
- 8
Spending by quarter
- 2025 Q3$1.4M
- 2025 Q4$670K
- 2026 Q1$2.3M
- 2026 Q2$1.7M
Issues lobbied
- Medicare & Medicaid
- Health care
- Pharmacy
- Taxes
- Copyright & patents
- Tariffs
- Trade
- Labor & antitrust
Bills lobbied on
- H.R. 94610 reports
- H.R. 14144 reports
- H.R. 591: Defending American Jobs and Investment Act4 reports
- H.R. 1990: American Innovation and R&D Competitiveness Act of 20253 reports
- H.R. 1262: Give Kids a Chance Act of 20253 reports
- H.R. 41323 reports
- S. 8643 reports
- H.R. 1: One Big Beautiful Bill Act2 reports
- S. 9982 reports
- H.R. 24232 reports
- H.R. 61662 reports
- H.R. 1672: Maintaining Investments in New Innovation Act2 reports
Lobbying firms hired
- Astrazeneca Pharmaceuticals LP$6M
- W Strategies, LLC$320K
- Todd Strategy Group$320K
Lobbyists who worked in Congress
- Eric Bergren
Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior…Brett Guthrie (R-KY) - Katherine Cotton
Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett GuthrieBrett Guthrie (R-KY) - Bailey Mccue
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator…John Boozman (R-AR) - Bailey Mccue
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021 Senator…John Cornyn (R-TX)
Agencies contacted
- House Of Representatives · 40
- Senate · 40
- White House Office · 13
- Centers For Medicare and Medicaid Services (Cms) · 11
- U.S. Trade Representative (Ustr) · 7
- Commerce, Dept of (Doc) · 5
Related
Filings
- 2026 Q2 report$1.7M
- 2026 Q2 report$80K
- 2026 Q2 report$80K
- 2026 Q1 report$2.3M
- 2026 Q1 report$80K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Astrazeneca Pharmaceuticals LP: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/castrazenecapharmaceuticals/astrazeneca-pharmaceuticals-lp (accessed 2026-10-13).